gravelc
Joined 10 years ago
Joined 10 years ago
They are now the 2nd biggest seller after Toyota (https://www.msn.com/en-au/news/insight/byd-overtakes-rivals-...).
They are also priced much lower than KIA and Tesla.
FWIW I now own a GWM Cannon Αlpha PHEV pickup. Have also owned a Jeep Wrangler - the tech, build quality and reliability is not even on the same planet.
I can't imagine how the US manufacturers would compete with the Chinese ones on a level playing field. Not from the US, but it's hard to see how any administration would allow that. Would be the end of the local industry.
https://www.drive.com.au/caradvice/are-mobile-billboards-leg...
I work on RNAi-based biopesticides (sprayed dsRNA) - non-GM, doesn't impact beneficial species, doesn't hang around in the environment, etc. Already ubiquitous in nature (and part of our diet). Peptide-based biopesticides are another approach that is going well. Both approaches are now commercialised by smaller players (e.g. for varroa mite control in bee hives by GreenLight), and not by the Bayer, Syngenta types.
https://population.un.org/wpp/graphs?loc=36&type=Probabilist...
Housing is very expensive, but inflation is largely tamed, unemployment is low, and the government is running surpluses - so things aren't terrible (despite what the Murdoch media say). Birth rates are falling, but I'm not sure how much that really matters given immigration.
I grew up in Australia with mutton making up 90% of my meat intake, as we slaughtered our own merino wethers (so not the breeds of lamb raised for eating).
The local butchers would also have a decent stock of different cuts, particularly things like neck chops for stews. Numbers of sheep around are lower now, so that may have limited things a little.
I also think hogget is equally as or more common than lamb in city butchers. Some of those chops are huge and have a nice tang.
- "Our work shows that TNT reprogramming is a practical and scalable approach to overcome these intrinsic characteristics of hiPS cells, which is important for the clinical delivery of this technology."